Seton Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SETON PHARMS, and what generic and branded alternatives to SETON PHARMS drugs are available?
SETON PHARMS has four approved drugs.
Drugs and US Patents for Seton Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-003 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206666-001 | Sep 28, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Seton Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | SOLUTION;ORAL | 210319-001 | Aug 31, 2020 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-001 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seton Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | FOR SOLUTION;INHALATION | 206667-001 | Apr 24, 2019 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-004 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-002 | Oct 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.